Literature DB >> 19626595

Recent developments in carbohydrate-decorated targeted drug/gene delivery.

Hailong Zhang1, Yong Ma, Xue-Long Sun.   

Abstract

Targeted delivery of a drug or gene to its site of action has clear therapeutic advantages by maximizing its therapeutic efficiency and minimizing its systemic toxicity. Generally, targeted drug or gene delivery is performed by loading a macromolecular carrier with an appropriate drug or gene, and by targeting the drug/gene carrier to specific cell or tissue with the help of specific targeting ligand. The emergence of glycobiology, glycotechnology, and glycomics and their continual adaptation by pharmaceutical scientists have opened exciting avenue of medicinal applications of carbohydrates. Among them, the biocompatibility and specific receptor recognition ability confer the ability of carbohydrates as potential targeting ligands for targeted drug and gene delivery applications. This review summarizes recent progress of carbohydrate-decorated targeted drug/gene delivery applications. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19626595     DOI: 10.1002/med.20171

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  17 in total

1.  Synthesis and in vitro inhibition properties of siRNA conjugates carrying glucose and galactose with different presentations.

Authors:  Anna Aviñó; Sandra M Ocampo; Ricardo Lucas; José J Reina; Juan Carlos Morales; José Carlos Perales; Ramon Eritja
Journal:  Mol Divers       Date:  2011-01-26       Impact factor: 2.943

2.  Dextran functionalization enhances nanoparticle-mediated siRNA delivery and silencing.

Authors:  Daniel Vocelle; Olivia M Chesniak; Amanda P Malefyt; Georgina Comiskey; Kwasi Adu-Berchie; Milton R Smith; Christina Chan; S Patrick Walton
Journal:  Technology (Singap World Sci)       Date:  2016-03-31

Review 3.  Integrating optogenetic and pharmacological approaches to study neural circuit function: current applications and future directions.

Authors:  Garret D Stuber; Alex O Mason
Journal:  Pharmacol Rev       Date:  2013-01-10       Impact factor: 25.468

4.  Preferences for uptake of carbohydrate-coated liposomes by C-type lectin receptors as antigen-uptake receptors.

Authors:  Yoko Kawauchi; Yasuhiro Kuroda; Naoya Kojima
Journal:  Glycoconj J       Date:  2012-06-26       Impact factor: 2.916

5.  Liposome surface functionalization based on different anchoring lipids via Staudinger ligation.

Authors:  Pratima Vabbilisetty; Xue-Long Sun
Journal:  Org Biomol Chem       Date:  2014-02-28       Impact factor: 3.876

6.  In vivo targeting of B-cell lymphoma with glycan ligands of CD22.

Authors:  Weihsu C Chen; Gladys C Completo; Darren S Sigal; Paul R Crocker; Alan Saven; James C Paulson
Journal:  Blood       Date:  2010-02-24       Impact factor: 22.113

7.  Liposomes modified by carbohydrate ligands can target B cells for the treatment of B-cell lymphomas.

Authors:  Geert-Jan Boons
Journal:  Expert Rev Vaccines       Date:  2010-11       Impact factor: 5.217

Review 8.  Targeted nanoagents for the detection of cancers.

Authors:  Jason R McCarthy; Jayeeta Bhaumik; Mark R Karver; S Sibel Erdem; Ralph Weissleder
Journal:  Mol Oncol       Date:  2010-09-08       Impact factor: 6.603

9.  Bimodal Targeting Using Sulfonated, Mannosylated PEI for Combined Gene Delivery and Photodynamic Therapy.

Authors:  Upendra Chitgupi; Yi Li; Mingfu Chen; Shuai Shao; Marie Beitelshees; Myles Joshua Tan; Sriram Neelamegham; Blaine A Pfeifer; Charles Jones; Jonathan F Lovell
Journal:  Photochem Photobiol       Date:  2017-02-07       Impact factor: 3.421

Review 10.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

Authors:  Nicolas Bertrand; Jun Wu; Xiaoyang Xu; Nazila Kamaly; Omid C Farokhzad
Journal:  Adv Drug Deliv Rev       Date:  2013-11-22       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.